Next-Generation Sequencing Reveals the Role of Epigallocatechin-3-Gallate in Regulating Putative Novel and Known microRNAs Which Target the MAPK Pathway in Non-Small-Cell Lung Cancer A549 Cells

Lung cancer constitutes 85% of non-small cell lung cancer diagnosed cases. MicroRNAs are novel biomarkers that are capable of modulating multiple oncogenic pathways. Epigallocatechin-3-gallate (EGCG) is a potent chemopreventive and chemotherapeutic agent for cancer. We aimed to identify important kn...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Vaishali Bhardwaj, Abul Kalam Azad Mandal
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI AG 2019-01-01
Serie:Molecules
Soggetti:
next-generation sequencing
microRNAs
A549
EGCG
MAPK pathway
Accesso online:https://www.mdpi.com/1420-3049/24/2/368
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi